logo

Zafgen, Inc (ZFGN)



Trade ZFGN now with
  Date
  Headline
8/8/2018 8:54:47 AM Wedbush Is Increasing Zafgen, Inc (ZFGN) FY19 Estimate To -1.82 From -1.97
8/8/2018 8:54:30 AM Wedbush Is Increasing Zafgen, Inc (ZFGN) FY18 Estimate To -1.99 From -2.09
8/8/2018 8:54:17 AM Wedbush Is Raising Zafgen, Inc (ZFGN) Q3 18 Estimate To -0.43 From -0.47
8/8/2018 8:53:49 AM Wedbush Reiterates Zafgen, Inc (ZFGN) At Outperform With $14 Price Target
8/2/2018 4:32:40 PM Navitor Pharmaceuticals Appoints Thomas Hughes As CEO
7/6/2018 5:06:09 AM In The Spotlight: Zafgen
6/28/2018 8:05:03 AM Zafgen Announces Pricing Of Offering Of 8 Mln Shares At $7.50/Shr
6/27/2018 4:04:00 PM Zafgen Announces Proposed Offering Of Common Stock
6/23/2018 10:34:36 AM Zafgen: Phase 2 Proof-of-Concept Trial Of ZGN-1061 Meets All Primary Objectives
6/7/2018 7:05:41 AM Zafgen Appoints Wendy Everett To Board
7/20/2016 9:32:27 AM FBR Capital Markets Is Raising Zafgen, Inc (ZFGN) 2017 Estimate To -1.48 From -2.85
7/20/2016 9:31:37 AM FBR Capital Markets Cuts Zafgen, Inc (ZFGN) To Market Perform From Outperform With $5 Down From $20 Price Target